Exelon Balance Sheet Health
Financial Health criteria checks 1/6
Exelon has a total shareholder equity of $26.6B and total debt of $46.1B, which brings its debt-to-equity ratio to 173.2%. Its total assets and total liabilities are $106.1B and $79.4B respectively. Exelon's EBIT is $4.3B making its interest coverage ratio 2.2. It has cash and short-term investments of $616.0M.
Key information
173.2%
Debt to equity ratio
US$46.12b
Debt
| Interest coverage ratio | 2.2x |
| Cash | US$616.00m |
| Equity | US$26.62b |
| Total liabilities | US$79.45b |
| Total assets | US$106.07b |
Recent financial health updates
We Think Exelon (NASDAQ:EXC) Is Taking Some Risk With Its Debt
Aug 01
Exelon (NASDAQ:EXC) Has A Somewhat Strained Balance Sheet
May 02Recent updates
Here's Why We Think Exelon (NASDAQ:EXC) Might Deserve Your Attention Today
Oct 22A Look At The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)
Oct 04Exelon Is A Reasonably Priced Utility For Income Investors
Sep 24There Is A Reason Exelon Corporation's (NASDAQ:EXC) Price Is Undemanding
Aug 25Exelon: Shares Still Undervalued, But Now With Higher Dividend And New Growth Potential
Jul 08Earnings Miss: Exelon Corporation Missed EPS By 5.8% And Analysts Are Revising Their Forecasts
May 05Exelon Corporation's (NASDAQ:EXC) Shareholders Might Be Looking For Exit
Apr 29Exelon: Rate-Base Scale, Cost Management Drive Upside Potential
Mar 29A Look At The Fair Value Of Exelon Corporation (NASDAQ:EXC)
Mar 18Risks To Shareholder Returns Are Elevated At These Prices For Exelon Corporation (NASDAQ:EXC)
Jan 08A Look At The Fair Value Of Exelon Corporation (NASDAQ:EXC)
Oct 27Are Exelon Corporation (NASDAQ:EXC) Investors Paying Above The Intrinsic Value?
Jul 24Exelon (NASDAQ:EXC) Is Increasing Its Dividend To $0.36
Apr 29Exelon Corporation's (NASDAQ:EXC) Intrinsic Value Is Potentially 21% Below Its Share Price
Apr 10Exelon's (NASDAQ:EXC) Shareholders Will Receive A Bigger Dividend Than Last Year
Feb 18Does This Valuation Of Exelon Corporation (NASDAQ:EXC) Imply Investors Are Overpaying?
Dec 30Estimating The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)
Sep 26Exelon: A Pure Play Transmission Firm Poised To Benefit From Utility Grid Transformation
Aug 31Exelon Q2 2022 Earnings Preview
Aug 02We Think Exelon (NASDAQ:EXC) Is Taking Some Risk With Its Debt
Aug 01Exelon Corporation declares $0.3375 dividend
Jul 26A Look At The Intrinsic Value Of Exelon Corporation (NASDAQ:EXC)
Jun 21Exelon's Corporate Transactions Will Likely Imply Higher Stock Price
May 17Exelon (NASDAQ:EXC) Has A Somewhat Strained Balance Sheet
May 02Exelon Corporation: On The Verge Of Proving Its Worth
Apr 15Financial Position Analysis
Short Term Liabilities: EXC's short term assets ($8.0B) exceed its short term liabilities ($7.4B).
Long Term Liabilities: EXC's short term assets ($8.0B) do not cover its long term liabilities ($72.1B).
Debt to Equity History and Analysis
Debt Level: EXC's net debt to equity ratio (170.9%) is considered high.
Reducing Debt: EXC's debt to equity ratio has increased from 109.8% to 173.2% over the past 5 years.
Debt Coverage: EXC's debt is not well covered by operating cash flow (12%).
Interest Coverage: EXC's interest payments on its debt are not well covered by EBIT (2.2x coverage).